Composition
Each enteric coated tablet contains:
| Doxylamine Succinate |
10 mg |
| Pyridoxine HCL IP |
10 mg |
| Folic Acid IP |
2.5 mg. |
| Excipients |
q.s. |
Doxylamine + Pyridoxine
- First-line agents for treatment of nausea and vomiting in pregnancy
- Decreases likelihood of severe morning sickness
- Prevents possible progression to Hyperemesis Gravidarum
- There is no risk for birth defects or other adverse pregnancy outcomes
Folic Acid
- Required for normal growth and cell reproduction, maintenance of erythropoiesis & for prevention of NTDs.
Indication
- Morning Sickness
- Hyperemesis Gravidarum
- Nausea
- Vomiting
